Announcement Regarding the Completion of Absorption-type Merger of Wholly-Owned Subsidiary (GENOVA DESiGN Inc.)
NQ Score
100/100
AI Summary (NQ-processed)
GENOVA Inc. has completed the absorption-type merger of its wholly-owned subsidiary, GENOVA DESiGN Inc. (GD Inc.), effective April 1, 2026. This merger aims to strengthen collaboration between GENOVA's medical platform business and its production department, accelerate decision-making, improve service quality, and enhance corporate value through reduced administrative costs. The merger, being with a 100% owned subsidiary, will not impact consolidated business performance.
AI analysis data is not yet available.